Ideal Implant Incorporated has Ceased Operations and is Liquidating
With deep regret, we must inform you that Ideal Implant Incorporated ceased all operations at 5:00 pm CT Tuesday, May 30, 2023. We have been unable to generate sufficient income from sales or to secure the capital investment necessary to maintain financial viability of the company. Through a formal search process, our investment bankers were unsuccessful in finding an investor or acquiror that would keep Ideal Implant operating. We had been in extensive negotiations that would have provided for past and future warranty claims to be assumed by the acquiror in exchange for signicant financial concessions, but negotiations with the potential acquiror ended unexpectedly late Tuesday afternoon. We were left with no other alternative than to cease operations and liquidate.
Effective immediately, no implants will be shipped and no returns will be accepted for credit. We do not have sufficient assets to satisfy our secured creditor, therefore, there are no assets or funds available for any other creditors of the company. Existing and future warranty claims cannot be processed and we have no funds available to pay any warranty claims. If you have questions about the liquidation process, please contact our attorney:
Jeffrey M. Rosenthal
Mandelbaum Barrett PC
3 Becker Farm Road, Suite 105
Roseland, NJ 07068
Ideal Implant was founded in January 2006. Since then, a dedicated team of engineers, consultants, administrators, advisors, sales representatives and investors has worked to develop and refine the Ideal Implant and make it available to women as an alternative to the original saline and silicone implants. We want to thank everyone for their professional and personal dedication to this goal over the last 17 years. Many surgeons and patients embraced this new technology implant and were happy with the clinical results. Unfortunately, the company does not have the financial resources to continue in business.